These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27347885)

  • 21. IGF-I abuse in sport.
    Guha N; Dashwood A; Thomas NJ; Skingle AJ; Sönksen PH; Holt RI
    Curr Drug Abuse Rev; 2009 Sep; 2(3):263-72. PubMed ID: 20443773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin, growth hormone and sport.
    Sonksen PH
    J Endocrinol; 2001 Jul; 170(1):13-25. PubMed ID: 11431133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-I and GH: potential use in gene doping.
    Harridge SD; Velloso CP
    Growth Horm IGF Res; 2009 Aug; 19(4):378-82. PubMed ID: 19487147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
    Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physiology of growth hormone and sport.
    Widdowson WM; Healy ML; Sönksen PH; Gibney J
    Growth Horm IGF Res; 2009 Aug; 19(4):308-19. PubMed ID: 19505835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ergogenic aids: human growth hormone.
    Stacy JJ; Terrell TR; Armsey TD
    Curr Sports Med Rep; 2004 Aug; 3(4):229-33. PubMed ID: 15231228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
    Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion.
    Fu YK; Arkins S; Wang BS; Kelley KW
    J Immunol; 1991 Mar; 146(5):1602-8. PubMed ID: 1847167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor.
    Sabharwal P; Varma S
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2663-9. PubMed ID: 8675594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone and a partial mediator of its biological action, insulin-like growth factor I.
    Pankov YA
    Biochemistry (Mosc); 1999 Jan; 64(1):1-7. PubMed ID: 9986906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
    Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The history of doping and growth hormone abuse in sport.
    Holt RI; Erotokritou-Mulligan I; Sönksen PH
    Growth Horm IGF Res; 2009 Aug; 19(4):320-6. PubMed ID: 19467612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human aging and the GH-IGF-I axis.
    Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use and Abuse of Growth Hormone in Sports.
    Holt RIG; Ho KKY
    Endocr Rev; 2019 Aug; 40(4):1163-1185. PubMed ID: 31180479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy.
    Soliman AT; Ramadan MA; Sherif A; Aziz Bedair ES; Rizk MM
    Metabolism; 2001 Aug; 50(8):905-11. PubMed ID: 11474477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in nutritional status].
    Chevenne D; Porquet D
    Ann Biol Clin (Paris); 1995; 53(10-11):527-38. PubMed ID: 8787278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of IGF-I in muscular atrophy of aging.
    Borst SE; Lowenthal DT
    Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone and connective tissue in exercise.
    Doessing S; Kjaer M
    Scand J Med Sci Sports; 2005 Aug; 15(4):202-10. PubMed ID: 15998337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse.
    Böhning D; Böhning W; Guha N; Cowan DA; Bartlett C; Sönksen PH; Holt RIG
    BMC Res Notes; 2018 Sep; 11(1):650. PubMed ID: 30185229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.